
---
title: '_医药基金女神_重仓股全名单，二季度以来或赚超67亿！最具潜力医药龙头曝光'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202106/W020210604311533465370.png'
author: 证券时报网
comments: false
date: Fri, 04 Jun 2021 08:34:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202106/W020210604311533465370.png'
---

<div>   
<p>“医药基金女神”葛兰重仓的医药股二季度至今浮盈近八成，仅<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" code="600276">恒瑞医药</a>持仓出现较大浮亏。</p><p>“月满则亏，水满则溢”，比喻事物发展到极点则开始衰退。对应到股市上，当一家公司估值或股价达涨到极致之后，就容易进入调整甚至走下坡路，这样的剧情在A股屡见不鲜。</p><p><strong>医药10倍股罕见大回撤</strong></p><p><strong>“医药基金女神”葛兰踩雷</strong></p><p>在新冠肺炎疫情肆虐期间声名大噪的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>，去年营收和净利润均达到历史新高，2020年股价涨幅高达14倍以上，坚定持仓的投资者也由此赚的盆满钵满，一度被市场誉为“手套茅”。今年1月25日公司股价历史性的逼近300元/股，市值突破千亿大关。在过去四个月，公司股价上涨乏力，尤其是6月2日以20%的跌幅跌停，创历史单日最大跌幅，6月3日股价再次下挫6.8%，迄今已跌破牛熊分界线。</p><p>经过两天连续大跌，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>市值跌破400亿元。与年初创下的历史高点相比，其累计回撤64.18%，A股市值蒸发600亿以上。就在大跌的前夜，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>发布减持公告。公司实控人、董事长刘方毅和四位高管计划在6个月内减持共计2201万股，占总股本的6.1%，减持原因为个人资金需求。如果以6月3日收盘价计算，刘方毅及<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>一众高管此番减持合计套现超过23亿元。</p><p><img src="https://data.stcn.com/djsj/202106/W020210604311533465370.png" title="微信图片_20210604070530.jpg" alt="微信图片_20210604070530.jpg" width="550" oldsrc="W020210604311533465370.png" referrerpolicy="no-referrer"></p><p>究竟是什么原因导致昔日医药牛股如此大幅回撤？业内人士表示，减持只是导火索，影响资本市场信心的根本原因是对<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>业绩不可持续的预期。随着新冠疫苗快速普及，疫情终将过去，这类突发事件导致的业绩暴增并不具备持续性。另外，许多企业在疫情期间陆续扩大一次性手套产能，疫情结束后，过剩的产能可能会导致产品滞销或降价。</p><p>如果按照一季度持仓情况粗略估算，仅仅因为<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>，“医药基金女神”葛兰管理的“中欧医疗健康混合型证券投资基金”（简称“中欧医疗健康混合”）二季度至今回撤幅度32.93%，损失金额约4.65亿。从持仓变动来看，一季度期间，葛兰管理的“中欧医疗健康混合”加仓了<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>约101万股，二季度以来是否增减持不得而知。</p><p><img src="https://data.stcn.com/djsj/202106/W020210604311533506247.png" title="1_副本.png" alt="1_副本.png" width="550" oldsrc="W020210604311533506247.png" referrerpolicy="no-referrer"></p><p><strong>葛兰重仓的医药股</strong></p><p><strong>4月至今浮盈或超67亿</strong></p><p>除了<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300677" code="300677">英科医疗</a>外，葛兰管理的“中欧医疗健康混合”一季度末重仓股<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" code="600276">恒瑞医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603229" code="603229">奥翔药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000661" code="000661">长春高新</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603939" code="603939">益丰药房</a>在二季度期间股价均出现了下跌，其中医药龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" code="600276">恒瑞医药</a>期间累计下跌10.33%。</p><p>总的来看，葛兰持仓股二季度以来的走势可圈可点，重仓的24股平均涨幅达到18.37%，跑赢同期沪指14个百分点。约八成股票二季度至今为上涨状态，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300595" code="300595">欧普康视</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS688179" code="688179">阿拉丁</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS688202" code="688202">美迪西</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>等6股累计涨幅超40%。据统计，仅6月以来的3个交易日内，葛兰重仓股中有<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300595" code="300595">欧普康视</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603127" code="603127">昭衍新药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS688179" code="688179">阿拉丁</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300363" code="300363">博腾股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>等5股创下历史新高。</p><p>假设葛兰4月以来持仓不变的情况下，期间重仓股浮盈合计约67.8亿元，其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300595" code="300595">欧普康视</a>等股浮盈在5亿元以上。</p><p>或许是出于对医药板块的看好，北上资金近期也在加仓葛兰重仓的24只医药股。数据显示，5月以来共有13股获得北上资金增持，5股遭减持。按照成交均价粗略计算，北上资金合计增持21.7亿元。增持金额最高的前五位依次是<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300595" code="300595">欧普康视</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603939" code="603939">益丰药房</a>。</p><p>从未来发展潜力来看，不少券商机构对葛兰重仓的医药股抱以期待。根据5家以上机构一致预测数据，共16股今后三年净利润均有望同比增长20%以上，7只千亿市值的医药龙头在列，包括<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000661" code="000661">长春高新</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300759" code="300759">康龙化成</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>等。（数据宝 梁谦刚）</p><p><img src="https://data.stcn.com/djsj/202106/W020210604311533569611.png" title="2_副本.png" alt="2_副本.png" width="550" oldsrc="W020210604311533569611.png" referrerpolicy="no-referrer"></p><p>声明：数据宝所有资讯内容不构成投资建议，股市有风险，投资需谨慎。</p><p style="line-height: 2em;"><br></p> 
  
</div>
            